InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Olwill Shane, Directeur du Développement. Insider active across 1 company, notably Pieris Pharmaceuticals, INC.. Cumulatively, 2 filings have been recorded. Activity tracked since 30 August 2021. The latest transaction was filed on 30 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
38,400 shares@ US$1.5250.0% of flowCommon StockSEC:0001562180-21-005712:0
38,400 shares@ US$1.5250.0% of flowCommon StockSEC:0001562180-21-005712
2 of 2 declarations
About Olwill Shane
Olwill Shane is the Chief Development Officer at PIERIS PHARMACEUTICALS, INC. He is responsible for product development strategy and innovation. Shane leverages his expertise to identify new opportunities and strengthen the company's market position.
